These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33312758)
1. Intratumoral CD103 Gu Y; Chen Y; Jin K; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W Oncoimmunology; 2020 Nov; 9(1):1844402. PubMed ID: 33312758 [TBL] [Abstract][Full Text] [Related]
2. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer. Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral CXCL13 Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral Foxp3 Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826 [TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating podoplanin Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820 [TBL] [Abstract][Full Text] [Related]
6. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients. Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266 [TBL] [Abstract][Full Text] [Related]
7. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients. Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216 [TBL] [Abstract][Full Text] [Related]
8. Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness. Cao Y; He H; Li R; Liu X; Chen Y; Qi Y; Yu K; Wang J; Lin C; Liu H; Zhang H; Li H; Chen L; Zhang P; Shen Z; Huang H; Sun Y; Zhang W; Qin J; Xu J Ann Surg; 2022 Jan; 275(1):e163-e173. PubMed ID: 32511132 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103 Li R; Liu H; Cao Y; Wang J; Chen Y; Qi Y; Lv K; Liu X; Yu K; Lin C; Zhang H; He H; Li H; Chen L; Shen Z; Qin J; Zhang W; Sun Y; Xu J Br J Cancer; 2020 May; 122(10):1525-1534. PubMed ID: 32205862 [TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses. Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral TIGIT Liu Z; Zhou Q; Wang Z; Zhang H; Zeng H; Huang Q; Chen Y; Jiang W; Lin Z; Qu Y; Xiong Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang J; Chang Y; Zhang W J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817209 [TBL] [Abstract][Full Text] [Related]
13. Functional Heterogeneity of CD4 Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P Front Immunol; 2018; 9():2654. PubMed ID: 30505306 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients. Lv K; Li R; Cao Y; Gu Y; Liu X; He X; Jin K; Fang H; Fei Y; Shi M; Liu H; Li H; He H; Lin C; Zhang H; Xu J Int J Cancer; 2021 Feb; 148(3):759-768. PubMed ID: 33105024 [TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients. He X; Cao Y; Gu Y; Fang H; Wang J; Liu X; Lv K; Yu K; Fei Y; Lin C; Liu H; Zhang H; Li H; Xu J; Li R; He H Ann Surg Oncol; 2021 Oct; 28(11):6439-6450. PubMed ID: 33738713 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of tumour-infiltrating CD103 Zhou Q; Ou Y; Dai X; Chen X; Wu S; Chen W; Hu M; Yang C; Zhang L; Jiang H Br J Cancer; 2023 Apr; 128(8):1466-1477. PubMed ID: 36759726 [TBL] [Abstract][Full Text] [Related]
17. Infiltration and Significance of CD103+CD8+ T Cells in Gastrointestinal Adenocarcinoma. Cai W; Wang H Biomed Res Int; 2022; 2022():7469041. PubMed ID: 36119930 [TBL] [Abstract][Full Text] [Related]
18. Intratumoral PD-1 Yu K; Gu Y; Zhang P; Fang H; Cao Y; Wang J; Lin C; Liu H; Zhang H; He H; Li R; Qin J; Li H; Xu J Br J Cancer; 2022 Nov; 127(9):1709-1717. PubMed ID: 36002752 [TBL] [Abstract][Full Text] [Related]
19. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842 [TBL] [Abstract][Full Text] [Related]
20. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8 Li R; Zhang H; Cao Y; Liu X; Chen Y; Qi Y; Wang J; Yu K; Lin C; Liu H; He H; Li H; Chen L; Shen Z; Qin J; Zhang W; Sun Y; Xu J Cancer Immunol Immunother; 2020 Jul; 69(7):1327-1336. PubMed ID: 32200421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]